Astec Lifesciences consolidated net profit rises 79.67% in the March 2022 quarter

Sales rise 58.20% to Rs 271.98 crore

Net profit of Astec Lifesciences rose 79.67% to Rs 43.05 crore in the quarter ended March 2022 as against Rs 23.96 crore during the previous quarter ended March 2021. Sales rose 58.20% to Rs 271.98 crore in the quarter ended March 2022 as against Rs 171.92 crore during the previous quarter ended March 2021.

For the full year,net profit rose 38.14% to Rs 89.86 crore in the year ended March 2022 as against Rs 65.05 crore during the previous year ended March 2021. Sales rose 21.93% to Rs 676.57 crore in the year ended March 2022 as against Rs 554.87 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales271.98171.92 58 676.57554.87 22 OPM %24.0722.21 -22.7720.11 - PBDT68.9438.70 78 155.48114.73 36 PBT58.3032.18 81 121.1389.07 36 NP43.0523.96 80 89.8665.05 38

Powered by Capital Market - Live News